These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17956439)

  • 1. Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Mitsi G; Chroni E
    Eur J Neurol; 2007 Nov; 14(11):e6. PubMed ID: 17956439
    [No Abstract]   [Full Text] [Related]  

  • 2. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
    Bonifati V
    Eur J Hum Genet; 2006 Oct; 14(10):1061-2. PubMed ID: 16835587
    [No Abstract]   [Full Text] [Related]  

  • 4. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Jankovic J
    Ann Neurol; 2005 Jun; 57(6):933-4. PubMed ID: 15929036
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
    Marongiu R; Ghezzi D; Ialongo T; Soleti F; Elia A; Cavone S; Albanese A; Altavista MC; Barone P; Brusa L; Cortelli P; Petrozzi L; Scaglione C; Stanzione P; Tinazzi M; Zeviani M; Dallapiccola B; Bentivoglio AR; Valente EM; Garavaglia B;
    Mov Disord; 2006 Aug; 21(8):1232-5. PubMed ID: 16622859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.
    Ozelius LJ; Senthil G; Saunders-Pullman R; Ohmann E; Deligtisch A; Tagliati M; Hunt AL; Klein C; Henick B; Hailpern SM; Lipton RB; Soto-Valencia J; Risch N; Bressman SB
    N Engl J Med; 2006 Jan; 354(4):424-5. PubMed ID: 16436782
    [No Abstract]   [Full Text] [Related]  

  • 11. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
    Lesage S; Dürr A; Tazir M; Lohmann E; Leutenegger AL; Janin S; Pollak P; Brice A;
    N Engl J Med; 2006 Jan; 354(4):422-3. PubMed ID: 16436781
    [No Abstract]   [Full Text] [Related]  

  • 12. [The absence of the common LRRK2 G2019S mutation in 120 young onset Hungarian Parkinon's disease patients].
    Balicza P; Bereznai B; Takáts A; Klivényi P; Dibó G; Hidasi E; Balogh I; Molnár MJ
    Ideggyogy Sz; 2012 Jul; 65(7-8):239-42. PubMed ID: 23074843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
    Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
    Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.
    Tan EK; Shen H; Tan LC; Farrer M; Yew K; Chua E; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yih Y; Skipper L; Liu JJ
    Neurosci Lett; 2005 Aug; 384(3):327-9. PubMed ID: 15955629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
    Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H
    Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413
    [No Abstract]   [Full Text] [Related]  

  • 16. LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.
    Civitelli D; Tarantino P; Nicoletti G; Cirò Candiano IC; Annesi F; De Marco EV; Carrideo S; Rocca FE; Condino F; Spadafora P; Pugliese P; D'Asero S; Morelli M; Paglionico S; Annesi G; Quattrone A
    Clin Genet; 2007 Apr; 71(4):367-70. PubMed ID: 17470139
    [No Abstract]   [Full Text] [Related]  

  • 17. G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
    Pchelina SN; Yakimovskii AF; Ivanova ON; Emelianov AK; Zakharchuk AH; Schwarzman AL
    Mov Disord; 2006 Dec; 21(12):2234-6. PubMed ID: 17044089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
    Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
    Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.
    Lu CS; Simons EJ; Wu-Chou YH; Fonzo AD; Chang HC; Chen RS; Weng YH; Rohé CF; Breedveld GJ; Hattori N; Gasser T; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2005 Dec; 11(8):521-2. PubMed ID: 16256409
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.
    Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S
    Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.